Abstract
BACKGROUND: Placental malaria (PM) is associated with prenatal malaise, but many PM+ infants are born without symptoms. As malaria has powerful immunomodulatory effects, we tested the hypothesis that PM predicts reduced T-cell responses to vaccine challenge.
METHODS: We recruited healthy PM+ and PM- infants at birth. At six and 12 months, we stimulated PBMCs with tuberculin purified protein derivative (PPD) and compared expression of CD154, IL-2 and IFNγ by CD4 T-cells to a negative control using flow cytometry.We measured the length, weight and head circumference at birth and 12 months.
RESULTS: IL-2 and CD154 expression were low in both groups at both timepoints, without discernable differences. Expression of IFNγ was similarly low at 6 months but by 12 months, the median response was higher in PM- than PM + infants (p = 0.026). The PM+ infants also had a lower weight (p = 0.032) and head circumference (p = 0.041) at 12 months, indicating lower growth rates.At birth, the size and weight of the PM+ and PM- infants were equivalent. By 12 months, the PM+ infants had a lower weight and head circumference than the PM- infants.
CONCLUSIONS: Placental malaria was associated with reduced immune responses 12 months after immune challenge in infants apparently healthy at birth.
| Original language | English |
|---|---|
| Pages (from-to) | 6 |
| Journal | BMC Infectious Diseases [E] |
| Volume | 12 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- CD4-Positive T-Lymphocytes
- CD40 Ligand
- Cells, Cultured
- Female
- Flow Cytometry
- Humans
- Infant
- Infant, Newborn
- Interferon-gamma
- Interleukin-2
- Leukocytes, Mononuclear
- Malaria
- Placenta Diseases
- Pregnancy
- Tuberculin
- Tuberculin Test
- Tuberculosis Vaccines